Dantrolene Sodium is a direct-acting skeletal muscle relaxant belonging to the hydantoin derivative class that is primarily indicated for the treatment of muscle spasticity associated with chronic conditions… Read more
Dantrolene Sodium is a direct-acting skeletal muscle relaxant belonging to the hydantoin derivative class that is primarily indicated for the treatment of muscle spasticity associated with chronic conditions such as spinal cord injuries, stroke, cerebral palsy, and multiple sclerosis. It functions by inhibiting calcium ion release from the sarcoplasmic reticulum, effectively reducing muscle contractions. This category provides access to high-quality reference standards for the active pharmaceutical ingredient, alongside related impurities, degradation products, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control testing. By utilizing accurately characterized reference materials, analysts can ensure compliance with regulatory standards, improve the precision of analytical assays, and reliably detect trace-level contaminants throughout the drug development lifecycle and routine batch analysis.